NCT02629562View on ClinicalTrials.gov

Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

July 31, 2016

Conditions

Clinical Pharmacology

Interventions

BIOLOGICAL

B12019 and Neulasta

GCSF, Growth Colony Stimulating Factor

Trial Locations (1)

89231

Nuvisan GmbH, Neu-Ulm

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Cinfa Biotech

INDUSTRY